Viyash Scientific Limited (VIYASH) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE807F01027
Key metrics
- Market Cap
- ₹11,477 Cr
- P/E Ratio
- 56.01
- EPS
- 4.69
- Book Value
- 71.3
- P/B Ratio
- 3.68
- ROE
- 5.69%
- ROCE
- 12.5%
- Debt / Equity
- 0.16
- Net Margin
- 5.28%
- Revenue Growth
- 13.28%
- Profit Growth
- 663.53%
- Dividend Yield
- —
- 52W High
- ₹298.00
- 52W Low
- ₹175.26
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Viyash Scientific Limited
Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally. The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.
- Headquarters
- Hyderabad, India
- Employees
- 2,900
- Promoter Holding
- 67.29%
The full Viyash Scientific Limited analysis
Create a free account to open the complete VIYASH deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.